Selasa, 26 Juni 2012

New Cancer Vaccines Offer Hope To Millions

New Cancer Vaccines Offer Hope To Millions

Editor's Choice
Main Category: Cancer / Oncology
Also Included In: Immune System / Vaccines
Article Date: 26 Jun 2012 - 3:00 PDT

email icon email to a friend   printer icon printer friendly   write icon opinions   <!-- rate icon rate article Advertisement


Patient / Public:5 stars

5 (1 votes)

Healthcare Prof:3 stars

3 (1 votes)


At present, Provenge - for the treatment of advanced prostate cancer - is the only cancer vaccine on the market and is only available in the United States. However, healthcare business analysts, GlobalData, predict that over the next six years there will be a significant increase in cancer vaccines.

Although there are interesting developments in both the prophylactic* and the therapeutic sectors of the cancer vaccine market, the developments in the therapeutic sector offer the most inspiring innovations.

* "Prophylactic" means for prevention, such as Gardasil, a vaccine which protects from HPV infection, and its most common complication, cervical cancer. "Therapeutic" means for treatment (they person already has the disease).

According to GlobalData, a series of first-in-class treatments have shown to be safe and well tolerated in clinical trials.

These vaccines include:

  • GV1001 for advanced pancreatic cancer

  • Biovaxld (Idiotype vaccine therapy) for follicular non-Hodgkin lymphoma

  • Allovectin-7 and OncoVEX for the treatment of melanoma
Currently, there are several adverse effects in treatments used to help individuals suffering from these cancers, ranging from high toxicity, to short-term or unpredictable efficacy.

The medical community hope that advances in the cancer vaccine industry can resolve these issues and change the way future cancer treatments are developed.

Cancer vaccines can also be used in conjunction with treatments, such as surgery, radiation, and chemotherapy.

In addition, numerous pharmaceutical companies, including Vical, Biovest International, NewLink Genetics Corporation and NovaRx Corporation, are focusing more attention on cancer vaccines.

Written by Grace Rattue


Copyright: Medical News Today
Not to be reproduced without permission of Medical News Today

Please use one of the following formats to cite this article in your essay, paper or report:

MLA


APA

Please note: If no author information is provided, the source is cited instead.



Add Your Opinion On This Article

'New Cancer Vaccines Offer Hope To Millions'

Please note that we publish your name, but we do not publish your email address. It is only used to let you know when your message is published. We do not use it for any other purpose. Please see our privacy policy for more information.

If you write about specific medications or operations, please do not name health care professionals by name.

All opinions are moderated before being included (to stop spam)

Contact Our News Editors

For any corrections of factual information, or to contact the editors please use our feedback form.

Please send any medical news or health news press releases to:

Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.



MediLexicon International Ltd Logo

Privacy Policy | Terms and Conditions

MediLexicon International Ltd
Bexhill-on-Sea, United Kingdom
MediLexicon International Ltd © 2004-2012 All rights reserved.
MNT (logo) is the registered EU trade mark of MediLexicon Int. Limited.

Everyday Health Network back to top | home | privacy policy

MediLexicon International Ltd Logo MediLexicon International Ltd
Bexhill-on-Sea, United Kingdom
MediLexicon International Ltd © 2004-2012 All rights reserved.
MNT (logo) is the registered EU trade mark of MediLexicon Int. Limited.

Tidak ada komentar:

Posting Komentar